204 related articles for article (PubMed ID: 6396147)
1. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
3. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ; Maluish AE; Stephenson PM; Davis NC
Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
[TBL] [Abstract][Full Text] [Related]
6. [Immunodiagnosis of colorectal cancers by the leukocyte adherence inhibition test].
Hudák J; Máriafoldy E; Nagy A; Szabó I; Baradnay G; Varga L
Orv Hetil; 1983 Aug; 124(34):2045-7. PubMed ID: 6355968
[No Abstract] [Full Text] [Related]
7. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of leucocyte adherence inhibition microassay using colorectal cancer cell lines.
Machida S; Yamauchi M; Sato M; Ishioka T; Takashima K; Nishikawa T; Fukushima M; Koie H
Gan; 1980 Jun; 71(3):387-92. PubMed ID: 6998824
[TBL] [Abstract][Full Text] [Related]
9. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
12. [Modification of leucocyte adherence inhibition (LAI) assay with 51Cr-labelled leucocytes (author's transl)].
Varga A; Stosiek P; Kasper M
Allerg Immunol (Leipz); 1980; 26(2):171-8. PubMed ID: 6449844
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
14. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
Ayeni AO; Thomson DM; MacFarlane JK; Daly D
Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
[TBL] [Abstract][Full Text] [Related]
15. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
18. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels.
Shani A; Ritts RE; Thynne GS; Weiland LH; Silvers A; Moertel CG; Go VL
Int J Cancer; 1978 Aug; 22(2):113-9. PubMed ID: 359486
[TBL] [Abstract][Full Text] [Related]
20. Limited value of leukocyte adherence inhibition in screening for colorectal neoplasia in high-risk groups.
Shani A; Rozen P; Fink A; Bass D; Fraser D; Bentwich Z
Cancer Detect Prev; 1989; 13(5-6):311-6. PubMed ID: 2743352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]